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though NK cells and T cells share a number of biolog- 
ical functions including cytotoxicity and lymphokine 
secretion (1), they appear to differ fundamentally in the struc- 
ture of their antigen receptors. Whereas T cells are known 
to recognize foreign antigens via their CD3-associated het- 
erodimeric ce/15 or 3'/g TCK, the antigen recognition struc- 
tures used by NK cells are still in the process of being duci- 
dated. In this respect, current evidence (2-5) suggests that 
NK cells express polymorphic (but nonrearranging) receptors 
that bdoug to the NKR-Pl and Ly-49 families in mouse and 
the recently doned p58 family in humans. The nature of the 
ligands recognized by NK cells is controversial, although there 
is functional evidence that both Ly-49 and p58 receptor fam- 
ilies may mediate negative signals upon engagement of par- 
ticular MHC class I alleles (2-5). In contrast, NKK-Pl 
receptors appear to bind to a heterogeneous group of carbo- 
hydrate ligands (6), thereby triggering effector functions uch 
as cytolysis (6, 7). 
NK and T cells probably arise from related but distinct 
developmental lineages (8). Whereas the majority of ce//3 or 
~///~ T cells depend upon the thymus for their development, 
NK cells develop normally in athymic (nude) mice. Further- 
more, recombination-deficient mu ant (RAG-/-  or SCID) 
mice have normal levels of NK cells despite the complete ab- 
sence of ce/B or "y//~ T cells. Nevertheless, it is likely that 
both NK and T cells arise from a common "lymphoid com- 
mitted" precursor cell, since both lineages (as weU as B cells) 
are absent in mice lacking the ikaros transcription factor, 
whereas other hematopoietic cells develop normally in these 
mutant mice (9). 
In view of the apparently distinct ligands recognized by 
NK cells and T cells, it is of considerable interest that a subset 
oflymphocytes sharing receptor structures common to both 
lineages has been identified in mice (10-12), rats (13), and 
humans (14, 15). In the mouse, the best-defined such popu- 
lation coexpresses the ce/B TCR and NKI.1 (16) (a member 
of the NKR-Pl family), although other subsets of mouse 
TCR-cx/fl cells expressing members of the Ly-49 family have 
been described (17, 18). This commentary will focus on 
NKI.1 + TCK-odfl + (hereafter referred to as NK1 + T) cells 
and, in particular, will summarize recent insights into their 
origin, specificity, and function. 
Phenotype and TCR Expression of NKI + T Cells 
The surface phenotype of NK1 + T cells is dramatically 
different from that of normal ce/fl T cells. As summarized 
in Table 1, NK1 + T cells express anumber of markers usu- 
ally associated with an activation/memory phenotype (but 
absent from naive T cells) such as CD44 ugh, CD45RB I~ 
and CD62L l~ In addition, NK1 + T cells express the IL-2R 
B chain (CD122), which is normally present on conventional 
NK cells but not T cells. Whereas most mature r T cells 
express either CD4 or CD8 coreceptors, NK1 + T cells are 
almost exclusively either CD4 + or CD4-8- .  
Another unique feature of NK1 + T cells relates to their 
TCK expression. In comparison with normal r T cells, 
NK1 + T cells express approximately threefold lower surface 
density of TCR-cx/fl and have often been referred to in the 
literature as TCK "intermediate" (TCR int) cells. Further- 
more, the TCR.usage of NK1 + T cells is heavily biased for 
both c~ and fl chains. Thus, most NK1 + T cells use one of 
only three Vfl domains (Vf18.2, Vfl7, or Vfl2) (19), and a 
single Vex domain (Vcd4) is highly overrepresented among 
NK1 + T cells but rarely used by conventional r T cells 
(20). The latter finding explains the earlier puzzling obser- 
vations of Taniguchi and co-workers (21), who identified a
subset of peripheral T cells expressing an invariant Vol14- 
Jc~281 rearrangement with no junctional diversity. 
Relationship ofNKI + T Cells to TCR int, Invariant VcrI4, and 
Ipr/eld T Cells 
An important (but not yet totally resolved) issue is the 
relationship of NK1 § T cells to other unusual TCK-ot//~ 
subsets. As noted above, both TCK i~t and invariant Votl4 
T cell subsets have been described. Although all NK1 + T 
cells are clearly of a TCR ~ phenotype, it has not been pos- 
sible technically to address whether other (NKI.1-) subsets 
of TCR. int cells exist. In this issue of the journal, Sato et al. 
(22) provide a partial solution to this problem. By taking 
advantage of the expression of IL-2RB on all TCR i"~ (but 
not conventional TCKhig h) cells, these authors show that 
NKI.1 defines only a subset of the TCR ~t population. Fur- 
ther analysis of CD4/8 phenotype indicates that most 
NKI.1 + TCR i~t cells are CD4 + or CD4-8- ,  whereas 
NKI.1- TCR i~t cells are mainly CD8 + . It should be noted 
that the CD8 + TCR int subset, while resembling NK1 + T 
cells in terms of surface phenotype, has not yet been defined 
in terms of TCR usage or function. 
The precise relationship between NK1 + T cells and in- 
variant Vo114 cells has been more difficult to ascertain be- 
cause of the absence of reliable antibodies against Vcd4. Using 
semiquantitative PCR, Lantz and Bendelac (20) recently 
demonstrated a marked enrichment of Vex14 + cells in 
CD44~s hCD4 + thymocytes (corresponding to the CD4 + 
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Table 1. Phenotype and TCR Repertoire of NK1 + T Cells, Conventional T Cells, and Ipr/gld T Cells 
Marker NK1 + T Naive T Memory T Ipr/gld T 
NKI.1 + - _ _ 
CD4/8 CD4 § or CD4 + or CD4 § or CD4-8- 
CD4- 8- CD8 § CD8 § 
B220 - - _ + 
CD44 (Pgp-1) High Low High High 
CD45RB Low High Low High 
CD62L (Mel 14) Low High Low +/ -  
CD24 (HSA) Low Low Low + / - 
CD122 (IL2-R3) High Low Low Low 
TCR-CD3 Intermediate High High Intermediate 
TCR V3 2, 7, 8.2 All All All 
TCR Vc~ 14 All All All 
Clonal deletion 
(endogenous superantigen) No Yes Yes Yes 
subset of thymic NK1 + T cells), and most T cell hybrids 
derived by fusion of this population to the BW5147 thymoma 
used the invariant Voe14-Jc~281 rearrangement. Thus, it ap- 
pears likely that most NK1 + T cells (but few conventional 
T cells) use Vo~14; however, it is not known whether other 
TCR int subsets (such as the CD8 + TCR in~ population de- 
scribed above) are likewise enriched in Vc~14 + cells. 
Mice homozygous for the Ipr or gld mutations (which are 
defective in functional Fas or Fas ligand, respectively) develop 
autoimmune syndromes accompanied by peripheral expan- 
sion of a unique subset of CD4-8- TCR-cff3 cells (23). 
These Ipr/gld T cells resemble NK1 + T cells in that they are 
TCR i"t and express certain activation markers such as 
CD44hish; however, they differ phenotypically from NK1 + 
T cells in that they express the B cell marker B220 and fail 
to express NKI.1 (Table 1). Furthermore, lpr/gld T cells and 
NK1 + T cells differ fundamentally in their TCR repertoires 
(Table 1). Whereas NK1 + T cells use a highly restricted 
subset of V3 and Va chains, Ipr/gldT cells have a much more 
diverse relx~toire (although V38 is somewhat ~ented) .  
Moreover, Ipr and gld T cells are subjected to deletional toler- 
ance in the presence of endogenous mouse mammary tumor 
virus superantigens, whereas NK1 + T cells in general are 
not. Hence, it appears that Ipr/gld T cells are not related to 
the NK1 + T lineage. 
Developmental Origin of NK1 + T Cells 
The developmental origin of NK1 § T cells is controver- 
sial. Historically, a T cell subset corresponding phenotypi- 
cally to NK1 + T cells was first identified among CD4-8- 
thymocytes (24, 25), although itwas not appreciated for some 
time that these cells actually express NKI.1 (11). Subsequently, 
NK1 + T ceils were observed in other lymphoid organs uch 
as spleen (10) and bone marrow (12) as well as in liver (26). 
NK1 + T cells resident in the thymus appear to develop in 
situ, since cells of the NKI.1 + TCR-ot/3 + phenotype can 
be generated in fetal thymus organ cultures established from 
14-d mouse embryos (27). Furthermore, neonatal thymus 
grafts implanted incongenitally athymic (nude) mice can give 
rise to small numbers of NK1 + T cells in recipient bone 
marrow and spleen (28), suggesting a thymus-dependent 
origin for at least some peripheral NK1 + T cells. Neverthe- 
less, NKI.1 + TCR-a l3  + cells are readily detectable in ex- 
trathymic tissues uch as bone marrow (12), spleen (29), and 
liver (30) of nude mice. Thus, it appears that NK1 + T cells 
can be of either thymus-dependent or -independent origin. 
This conclusion is compatible with the finding that NK1 + 
T cells require xpression of an endogenous ligand on hema- 
topoietic ells (but not specialized epithelial cells) for their 
development (26, 27, 31). 
New evidence for the extrathymic origin of at least some 
NK1 + T cells is presented by Sato et al. in this issue (22). 
In particular, these authors how that NK1 + T cells (and 
other TCR i~t cells) develop selectively in the liver and spleen 
of thymectomized irradiated F1 mice reconstituted with pa- 
rental or syngeneic bone marrow cells. In control (euthymic) 
irradiated mice, both NK1 + T and conventional (TCR hiSh) 
T cells develop in these organs; however, the development 
of normal T cells is delayed relative to NK1 + T cells. The 
bone marrow precursors of NK1 + T cells in this adoptive 
transfer system express Thy-1 but not the TCR-CD3 com- 
plex. The findings of Sato et al. (22) are reminiscent of ear- 
lier reports in which TCR-c~/3 + cells were shown to be 
generated invitro from bone marrow precursors (32-34); how- 
ever, a very recent study indicates that most TCR-a/3 + 
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cells produced in short-term bone marrow cultures from Thy- 
1 + TCK-a/f l -  precursors are in fact NKI.1- (35). 
If NK1 + T ceils do indeed arise extrathymically, it should 
in theory be possible to demonstrate activity of the recom- 
binase-activating genes (RAGs) (which are essential for TCR 
rearrangement) in NK1 + T precursor cells in the corre- 
sponding tissues. In this regard, RAG-1 and RAG-2 mes- 
senger KNA have been detected previously by PCR in liver 
mononuclear ceils (36); however, no RAG-1 transcripts could 
be detected in liver by Northern blot in a subsequent s udy 
(37). Interestingly, Sato et al. (22) find that RAG-1 transcripts 
are expressed at much higher levels among liver mononuclear 
cells of reconstituted radiation bone marrow chimeras than 
in normal mouse liver. These data are consistent with an in- 
creased rate of extrathymic TCK-a/f l  rearrangement in
NK1 + T cell precursors in the chimeric animals. 
Ligand Specificity of NK1 + T Cells 
As mentioned above, most NK1 + T ceils express aTCK 
with a limited fl chain (V~8.2, Vfl7, or Vfl2) and virtually 
invariant a chain (Va14-Jot281) usage. It therefore seems likdy 
that the ligand(s) for this TCK will be highly restricted (or 
even monomorphic). Several experiments in vivo using gene- 
targeted "knockout" mice have provided ues as to the poten- 
tial ligands that control NK1 + T ceil development. Thus, 
it is dear that NK1 + T cells in thymus (27, 31, 38) or liver 
(26), as well as the related Vot14 + peripheral T cell subset 
(39), fail to develop in fl2-microglobulin (fl2-m)-deficient 
mice, suggesting that a flzm-assodated (i.e., MHC class I or 
rdated) molecule is a component of the ligand of the NK1 + 
T cell receptor. Further insight into the nature of this puta- 
tive ligand comes from recent analysis of mice deficient for 
the peptide transporter-associated protein 1 (TAP-l). In these 
mice, which lack conventional MHC class I molecules (H-2K, 
D and L), Vc~14 + T cells (and hence, presumably, most 
NK1 + T cells) develop normally (39). Taken together, the 
data with mutant mice suggest hat NK1 + T cells recog- 
nize a flzm-assodated molecule that does not require pep- 
tides transported by TAP-1 for its assembly and surface x- 
pression. Interestingly, there are at least wo wdl-characterized 
molecules that fulfill these criteria: the thymus leukemia n- 
tigen (40) and CD1 (41). In this context, Taniguchi and co- 
workers have identified a wild mouse strain in which 
Vcd4 + T cells do not devdop. In F2 backcross analysis, this 
defect segregates as a single recessive gene that is unlinked 
to the MHC (39). If, indeed, the absence of Val4 + ceils 
in these wild mice reflects a defect in the ligand responsible 
for NK1 + T cell development, hen it follows that the 
thymus leukemia ntigen (which is dosdy linked to the MHC) 
cannot be the relevant ligand. 
The case favoring CD1 as a potential ligand for NK1 + T 
cdls has been greatly strengthened by very recent analysis 
of the specificity of NK1 + T hybridomas. Thus, Bendelac 
et al. (42) demonstrated that several hybridomas bearing the 
invariant Vc~14-Jc~281 rearrangement could be stimulated to 
produce lymphokines in vitro after exposure to CD1- 
expressing thymocytes or fibroblasts infected with a vaccinia 
construct containing the mouse CD1 gene. Furthermore, this 
stimulation could be inhibited by mAbs to either the TCK 
or to CD1. Weaker eactivity of freshly isolated normal thymic 
NK1 § T cells to CDl-expressing fibroblasts could also be 
demonstrated. These data provide the first convincing evi- 
dence that CD1 is a component of the physiological ligand 
recognized by the TCK on NK1 + T ceils. It will be of great 
interest o determine whether CD1 can associate with pep- 
tides or other nonpeptidic moieties to stimulate NK1 + T 
cells. In this respect, it is known that some human TCK- 
odfl + clones can recognize mycolic acid (a mycobacterial ceil 
waU product) in association with CDlb (43). 
In considering the possible ligands recognized by NK1 + 
T cells, it should be emphasized that the potential contribu- 
tion of the NKI.1 molecule itself to ligand specificity cannot 
be discounted. Indeed, NKI.1 is a member of the NKK-Pl 
family of C-type (calcium-dependent) lectins, and there is 
evidence that at least some members of this family may in- 
teract with complex oligosaccharides present on the surface 
of certain "NK-susceptible" target cells (6). In conventional 
NK cdls, this interaction apparently leads to activation of 
the cytolytic program (6, 7). Furthermore, both NK cells 
(2) and activated NK1 + T cells (44) are capable of redirected 
lysis of Fc receptor-bearing target ceils in the presence of anti- 
NKI.1 antibodies. Collectivdy, these data raise the possibility 
that the NKI.1 molecule on NK1 + T cells (or another 
NKR-Pl family member) may confer specificity for an 
oligosaccharide ligand and/or a carbohydrate component of 
a complex ligand (perhaps involving CD1) that is corecog- 
nized by the ot/fl TCR. In the latter case, NKI.1 could be 
considered as a type of coreceptor molecule that modifies the 
avidity of TCR-ligand interactions on NK1 + T ceils. This 
speculative model (Fig. 1) is further supported by the fact 
that the cytoplasmic domains of NKR-P1 family members 
share a motif (Cys-X-Cys-Pro) that has been shown to be 
involved in the association of CD4 and CD8 coreceptors with 
the tyrosine kinase p561ck (2). However, no direct evidence 
for a molecular association between p561ck and NKI.1 has 
been reported. 
Function of NK1 + T Cells 
Because of the lack of precise knowledge of their ligand 
specificity, the function of NK1 + T ceils under physiolog- 
ical conditions has been difficult to address. However, the 
functional potential of NK1 + T cells has been investigated 
in vivo and in vitro by triggering their TCK-CD3 complex 
with mAbs. Such studies have shown a remarkable ability 
of NK1 + T cells to produce large amounts of cytokines and, 
in particular, IL-4. Indeed, it is likely that virtually all the 
IL-4 produced in vitro by anti-CD3-stimulated thymocytes 
can be accounted for by the NKI.1 + T subset (45, 46), and 
similar conclusions have been reached for splenic T ceUs from 
normal mice injected with anti-CD3 mAbs (47). As pointed 
out by others (47), this property of NK1 + T ceils may have 
important implications for the development of conventional 
CD4 + TCR-c~/fl + ceils of the Th2 cytokine profile, since, 
in many systems, Th2 cells arise preferentially (or exclusively) 
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Figure 1. Specuhtive coreceptor model for CD1 ligand recognition by 
NK1 + T cells. In this model, the highly conserved TCK-ot/B on NK1 + 
T cells reacts with the nonpolymorphic CD1 molecule. At the same time, 
the extracellular C-type lectin domain of NKI.1 interacts with a carbohy- 
drate moiety on CD1 to stabilize TCR binding. By analogy with CD4 
and CD8 on conventional T cells, NKI.1 could thus signal as a coreceptor 
via its putative cytoplasmic association with the tyrosine kinase p561ck. 
It is not known whether t  peptide-binding groove of CD1 is occupied, 
and the putative carbohydrate moiety could be of either endogenous or 
exogenous origin. Note that NKI.1 is a homodimer and hence could the- 
oretically cross-link TCR-CD1 complexes. 
under conditions of stimulation where IL-4 is already present. 
Indeed, it has been shown recently that CD4 + cells with a 
CD62L l~ phenotype (a population that includes NK1 + T 
cells) are required to direct the in vitro differentiation ofTh2 
cells from naive CD4 + precursors (48). 
Unlike conventional NK cells, NK1 + T cells appear not 
to lyse NK-sensitive target calls such as YAC-1 when freshly 
isolated ex vivo; however, they are capable of redirected lysis 
of Fc receptor-bearing target cells in the presence of anti- 
bodies to the TCR-CD3 complex (11). Furthermore, NK1 + 
T cells (like NK cells) can be induced to kill tumor ceils after 
exposure to cytokines uch as IL-2 and IL-4 in vitro (44, 49, 
50) or IL-12 in vivo (30). Interestingly, even freshly isolated 
thymic NK1 + T cells are able to lyse normal cortical 
(CD4 +8 +) thymocytes, apparently via the Pas-mediated 
pathway (51). Since cortical thymocytes express the putative 
NK1 + T cell ligand CD1 (52), it is possible that NK1 + 
T cells may play a role in thymic selection or homeostasis. 
Are NKI + T Cells "Suppressor" Cells? 
No discussion of NK1 + T cells would be complete 
without reforence to their possible relationship to suppressor 
cells. Indeed, the invariant Vot14-Jot281 rearrangement that 
is now known to be characteristic of most NK1 + T ceils 
was first identified as a conserved rearrangement i  a panel 
of KLH-specific suppressor cell hybridomas (53), and other 
suppressor T cell hybridomas pecific for antigens uch as 
DNP use the identical ot chain (54). Although the actual mech- 
anism of suppression mediated by such hybridomas i still 
not well defined, it is tempting to speculate that NK1 + T 
cells may in general be involved in negative regulatory func- 
tions, perhaps facilitated by their cytolytic activity and potential 
to secrete large amounts of inhibitory cytokines. 
A more physiological regulatory function f NK1 + T 
cells relates tothe supression of hemopoiesis. It has been known 
for many years that irradiated F1 mice frequently reject pa- 
rental bone marrow grafts. The phenomenon, known as hy- 
brid resistance, is genetically complex and involves the par- 
ticipation of NKI.1 + effector cells (55). Whereas it was 
initially assumed that these ffector cells are conventional NK 
cells, several studies clearly implicate NK1 + T cells in hy- 
brid resistance (10, 56). This issue is currently controversial, 
and it is possible that both NK and NK1 + T cells may be 
involved in the suppression of hemopoiesis (55). 
NKI + T Cells Expressing TCR-'y/$ 
This commentary has focused on the well-established subset 
of NK1 + T cells that expresses TCR-c,//~. However, in this 
issue of the journal, Arase et al. (57) describe anovel popula- 
tion of TCR-3,//~ + NK1 + T cells that is present in very 
low frequency in normal thymus. Interestingly, TCR~//~ + 
NK1 + T cells are increased ramatically in the thymus of 
CD3-~'-deficient mice, where, in contrast, mature TCR- 
o~//~ + cells (indnding the NK1 + T subset) fail to develop. 
By analogy to conventional TCR-3d6 + cells present in the 
gut epithelium (58), it is likely that thymic TCR-'y//~ + 
NK1 + T cells are able to develop in CD3-~'-deficient mice 
because the CD3~'-chain i  their TCR complex can be sub- 
stituted by the homologous FceRI ~/chain, which normally 
assodates with CD16 to form the high atfinity Fc receptor 
(59, 60). In any event, it will be of considerable interest o 
further characterize this novel NKI.1 + TCR-3'//5 + subset in 
terms of its origin and function. Given the paucity of infor- 
mation concerning the physiological ligand recognized by con- 
ventional TCR-3,//~ cells, it will be particularly challenging 
to address the specificity of the NK1 § TCR-34/~ receptor. 
As a first approach, it will obviously be informative to inves- 
tigate whether V gene usage is biased in these cells, as is the 
case for the TCR-ot/B + NK1 + T subset. 
Concluding Remarks 
NK1 + T calls represent a fascinating subset of TCR-ot/3 
(and apparently TCR-3,//~) ceils with poorly defined ligand 
specificity. As outlined here, it appears likely that NK1 + T 
cells can develop independently in several extrathymic tissues 
(notably bone marrow and liver) as well as in the thymus. 
Because of their ability to secrete large amounts oflL-4 upon 
TCR engagement, NK1 + T cells may play a pivotal role 
in Thl/Th2 lineage commitment of conventional CD4 + 
TCR.-a/• + cells. Furthermore, the potential of NK1 + T 
cells to mediate target cell lysis under certain conditions may 
allow them to carry out other regulatory functions, such as 
the suppression of immune responses or of hemopoiesis. U1- 
timatdy, NK1 + T cells may turn out to be bona fide regula- 
tory T cells that can even be discussed openly in public (61). 
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